PEDIATRICS Vol. 24 No. 5 November 1959, pp. 752-760
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Wyk, J. J.
Right arrow Articles by Pepper, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Wyk, J. J.
Right arrow Articles by Pepper, F.

THE EFFECTS OF A SOYBEAN PRODUCT ON THYROID FUNCTION IN HUMANS

Judson J. Van Wyk M.D.1, Mary B. Arnold M.D.1, James Wynn M.D.1, and Francis Pepper M.D.1

1 Departments of Pediatrics and Radiology, University of North Carolina School of Medicine, and Departments of Medicine, Veterans Administration Hospital, and Duke Medical Center, Durham, North Carolina

A 10-month-old infant reared on a soybean product (Mull-Soy®) from birth developed a goiter and hypothyroidism, which was cured by the administration of 4 drops of Lugol's solution and the replacement of the soybean product by whole cow's milk.

After this soybean product was withdrawn but while the patient was still hypothyroid, the thyroid had a high uptake of I131 with rapid discharge into the blood as PBI131. Reinstitution of this soybean product suppressed the thyroidal uptake of I131 and completely inhibited the appearance of PBI131 in the plasma.

Studies in normal adult subjects revealed that this soybean product did not interfere with the absorption of iodine, iodine uptake by the thyroid, oxidation of iodide to iodine or the release of PBI131 in most subjects. Two subjects, however, who had a high plasma level of PBI131 while receiving whole cow's milk had a significant suppression in the PBI131 while receiving this soybean product. This was not associated with a concomitant reduction in the plasma PBI127 thereby indicating that excessive loss of hormonal iodine bad not taken place.

These studies suggested that a goitrogenic agent was present in this particular soybean product, which interfered with thyroid hormone synthesis in susceptible individuals, and which raised the daily requirement for iodine.

Submitted on June 19, 1959
Accepted on July 28, 1959




This article has been cited by other articles:


Home page
 J. Nutr.Home page
C. W. Xiao
Health Effects of Soy Protein and Isoflavones in Humans
J. Nutr., June 1, 2008; 138(6): 1244S - 1249S.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
G I Varughese, A A Tahrani, J Davis, R N Clayton, and F W F Hanna
Caveats in treating thyroid disease: practical implications
J R Soc Med, November 1, 2006; 99(11): 582 - 583.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
R. J. Merritt and B. H. Jenks
Safety of Soy-Based Infant Formulas Containing Isoflavones: The Clinical Evidence
J. Nutr., May 1, 2004; 134(5): 1220S - 1224S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. W. Xiao, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, I. H. Curran, and S. A. Papademetriou
Dietary Soy Protein Isolate and Isoflavones Modulate Hepatic Thyroid Hormone Receptors in Rats
J. Nutr., April 1, 2004; 134(4): 743 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S C Conrad, H Chiu, and B L Silverman
Soy formula complicates management of congenital hypothyroidism
Arch. Dis. Child., January 1, 2004; 89(1): 37 - 40.
[Abstract] [Full Text] [PDF]